Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labor induction

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 6, 2000, Pages 1616-1619

  Ramsey, Patrick S ^a   Ogburn, Paul L ^a   Harris, Denise Y ^a   Heise, Robert H ^a   Ramin, Kirk D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cervical ripening; Labor induction; Misoprostol; Prostaglandins; Vaginal pH

Indexed keywords

MISOPROSTOL;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LABOR; LABOR INDUCTION; PH MEASUREMENT; PRIORITY JOURNAL; UTERINE CERVIX DILATATION;

EID: 0033936399     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107441     Document Type: Article

References (20)

1. 1. Hayashi RH. Spontaneous and induced cervical ripening: Natural dilation and effacement process and current cervical ripening techniques. J Reprod Med 1993;38:66-72.
2. 2. Trofatter KF. Cervical ripening. Clin Obstet Gynecol 1992;35: 476-86.
3. 3. Keirse MJNC. Prostaglandins in preinduction cervical ripening: Meta-analysis of worldwide clinical experience. J Reprod Med 1993;38:89100.
4. 4. Uldbjerg N, Ulmsten U, Ekman G. The ripening of the human uterine cervix in terms of connective tissue biochemistry. Clin Obstet Gynecol 1983;26:14-26.
5. 5. Theobald PW, Rath W, Kuhnle H, Kuhn W. Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix, and the pregnant prostaglandin-treated cervix. Arch Gynecol 1982;231: 241-5.
6. 2. Gynecol Obstet Invest 1983;15:291-9.
7. 7. Ramsey PS, Harris DY, Ogburn PL Jr, Heist RH, Magtibay PM, Ramin KD. Comparative efficacy of prostaglandin analogues dinoprostone and misoprostol as labor preinduction agents [abstract]. Am J Obstet Gynecol 1998;178 (1 Pt 2):S94.
8. 1 analog, for prelabor ripening of the unfavorable uterine cervix. Fetal Matern Med Rev 1996;8:217-27.
9. 9. Sanchez-Ramos L, Kaunitz AM, Wears RL, Isaac D, Gaudier FL. Misoprostol for cervical ripening and labor induction: a metaanalysis. Obstet Gynecol 1997;89:633-42.
10. 10. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1996;175: 158-64.
11. 1 analog misoprostol for labor induction. Am J Obstet Gynecol 1997;177:364-71.
12. 12. Toppozada MK, Anwar MYM, Hassan HA, El-Gazaerly WS. Oral or vaginal misoprostol for induction of labor. Int J Gynaecol Obstet 1997;56:135-9.
13. 13. Adair CD, Weeks JW, Barrilleaux S, Edwards M, Burlison K, Lewis DF. Oral or vaginal misoprostol for induction of labor: a randomized, double blind trial. Obstet Gynecol 1998;92: 810-3.
14. 14. Gemzell-Danielsson K, Marions L, Rodriquez A, Spur BW, Wong PYK, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93:275-80.
15. 15. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
16. 1 analog. J Clin Pharmacol 1989;29:439-43.
17. 17. Brand DL, Roufail WM, Thomson ABR, Tapper EJ. Misoprostol, a synthetic PGEI analog, in the treatment of duodenal ulcers: a multicenter double-blind study. Dig Dis Sci 1985;30:147S-58S.
18. 18. Nichlson PA. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients. Dig Dis Sci 1985;30 (Suppl):171S-7S.
19. 19. Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:266-8.
20. 20. Physicians' Desk Reference. 50th ed. Montvale (NJ): Medical Economics; 1996. p. 2424-6.